scispace - formally typeset
H

Hai Rim Shin

Researcher at World Health Organization

Publications -  71
Citations -  6134

Hai Rim Shin is an academic researcher from World Health Organization. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 26, co-authored 71 publications receiving 5509 citations. Previous affiliations of Hai Rim Shin include International Agency for Research on Cancer.

Papers
More filters
Journal ArticleDOI

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

Silvia de Sanjosé, +62 more
- 01 Nov 2010 - 
TL;DR: HPV types 16, 18, 31, 33, 35, 45, 52, and 58 should be given priority when the cross-protective effects of current vaccines are assessed, and for formulation of recommendations for the use of second-generation polyvalent HPV vaccines, according to this largest assessment of HPV genotypes to date.
Journal ArticleDOI

Epidemiology of cholangiocarcinoma: an update focusing on risk factors.

TL;DR: In this article, a meta-analysis of published literature revealed the summary relative risks of infection with liver fluke (both Opistorchis viverrini and Clonorchis sinensis), hepatitis B virus, and hepatitis C virus to be 4.8 (95% confidence interval [95% CI]: 2.8-8.4, 2.6 ( 95% CI: 1.5-4.6), and 1.4-2.4), respectively.
Journal ArticleDOI

Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva

Silvia de Sanjosé, +52 more
TL;DR: Combined data from HPV-DNA and p16(INK4a) testing are likely to represent a closer estimate of the real fraction of IVC induced by HPV, indicating that HPV contribution in invasive vulvar cancer has probably been overestimated.
Journal ArticleDOI

Cancer Statistics in Korea: Incidence, Mortality and Survival in 2006-2007

TL;DR: The nationwide cancer statistics in this paper will provide essential data for cancer research and evidence-based health policy in Korea and notable improvement has been observed in the 5-yr relative survival rates for most major cancers and for all cancer combined, with the exception of pancreatic cancer.